Erattum

Clinical benefits of bicalutamide compared with flutamide in combined androgen blockade for patients with advanced prostatic carcinoma: Final report of a double-blind, randomized, multicenter trial (Urology (September 1997) 50 (330-336))

P. F. Schellhammer, R. Sharifi, Norman L Block, M. S. Soloway, P. M. Venner, A. L. Patterson, M. F. Sarosdy, N. J. Vogelzang, J. J. Schellenger, G. J C M Kolvenbag

Research output: Contribution to journalArticle

Original languageEnglish
JournalUrology
Volume51
Issue number2
DOIs
StatePublished - Jan 1 1998
Externally publishedYes

Fingerprint

Flutamide
Urology
Androgens
Multicenter Studies
Carcinoma
bicalutamide

ASJC Scopus subject areas

  • Urology

Cite this

Erattum : Clinical benefits of bicalutamide compared with flutamide in combined androgen blockade for patients with advanced prostatic carcinoma: Final report of a double-blind, randomized, multicenter trial (Urology (September 1997) 50 (330-336)). / Schellhammer, P. F.; Sharifi, R.; Block, Norman L; Soloway, M. S.; Venner, P. M.; Patterson, A. L.; Sarosdy, M. F.; Vogelzang, N. J.; Schellenger, J. J.; Kolvenbag, G. J C M.

In: Urology, Vol. 51, No. 2, 01.01.1998.

Research output: Contribution to journalArticle

Schellhammer, P. F. ; Sharifi, R. ; Block, Norman L ; Soloway, M. S. ; Venner, P. M. ; Patterson, A. L. ; Sarosdy, M. F. ; Vogelzang, N. J. ; Schellenger, J. J. ; Kolvenbag, G. J C M. / Erattum : Clinical benefits of bicalutamide compared with flutamide in combined androgen blockade for patients with advanced prostatic carcinoma: Final report of a double-blind, randomized, multicenter trial (Urology (September 1997) 50 (330-336)). In: Urology. 1998 ; Vol. 51, No. 2.
@article{72064785a8ac40d8977eca31c0e71a92,
title = "Erattum: Clinical benefits of bicalutamide compared with flutamide in combined androgen blockade for patients with advanced prostatic carcinoma: Final report of a double-blind, randomized, multicenter trial (Urology (September 1997) 50 (330-336))",
author = "Schellhammer, {P. F.} and R. Sharifi and Block, {Norman L} and Soloway, {M. S.} and Venner, {P. M.} and Patterson, {A. L.} and Sarosdy, {M. F.} and Vogelzang, {N. J.} and Schellenger, {J. J.} and Kolvenbag, {G. J C M}",
year = "1998",
month = "1",
day = "1",
doi = "10.1016/S0090-4295(98)00091-0",
language = "English",
volume = "51",
journal = "Urology",
issn = "0090-4295",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Erattum

T2 - Clinical benefits of bicalutamide compared with flutamide in combined androgen blockade for patients with advanced prostatic carcinoma: Final report of a double-blind, randomized, multicenter trial (Urology (September 1997) 50 (330-336))

AU - Schellhammer, P. F.

AU - Sharifi, R.

AU - Block, Norman L

AU - Soloway, M. S.

AU - Venner, P. M.

AU - Patterson, A. L.

AU - Sarosdy, M. F.

AU - Vogelzang, N. J.

AU - Schellenger, J. J.

AU - Kolvenbag, G. J C M

PY - 1998/1/1

Y1 - 1998/1/1

UR - http://www.scopus.com/inward/record.url?scp=0031939035&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031939035&partnerID=8YFLogxK

U2 - 10.1016/S0090-4295(98)00091-0

DO - 10.1016/S0090-4295(98)00091-0

M3 - Article

VL - 51

JO - Urology

JF - Urology

SN - 0090-4295

IS - 2

ER -